30 results about "Percutaneous aortic valve replacement" patented technology

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices may be adapted for use in minimally invasive or endovascular surgical procedures.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures.

Inflatable medical devices and methods for making and using the same are disclosed. The inflatable medical devices can be medical balloons. The balloons can be configured to have a through-lumen or no through-lumen and a wide variety of geometries. The device can have a high-strength, non-compliant, fiber-reinforced, multi-layered wall. The inflatable medical device can be used for angioplasty, kyphoplasty, percutaneous aortic valve replacement, or other procedures described herein.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures. The preferred delivery device includes a catheter having a deployment mechanism attached to its distal end, and a handle mechanism attached to its proximal end. A plurality of tethers are provided to selectively restrain the valve during deployment. A number of mechanisms for active deployment of partially expanded prosthetic valves are also described.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures.

The present invention provides devices and methods for the treatment of cardiovascular valve diseases such as aortic stenosis. A vascular valve assembly is formed from two or more valve devices, each of which contains a valve mounted in a stent. The individual valve devices are brought to the site of the defective valve by standard percutaneous catheterization methods. Lateral expansion of the stents at the site of valve replacement produces a functioning valve assembly. Appropriate sizing and number of valve devices prevents regurgitation and migration. The assembly of two or more smaller valve devices at the site of a defective valve prevents complications due to the large size of single valve prostheses.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures. The preferred delivery device includes a catheter having a deployment mechanism attached to its distal end, and a handle mechanism attached to its proximal end. A plurality of tethers are provided to selectively restrain the valve during deployment. A number of mechanisms for active deployment of partially expanded prosthetic valves are also described.

Inflatable medical devices and methods for making and using the same are disclosed. The inflatable medical devices can be medical balloons. The balloons can be configured to have a through-lumen or no through-lumen and a wide variety of geometries. The device can have a high-strength, non-compliant, fiber-reinforced, multi-layered wall. The inflatable medical device can be used for angioplasty, kyphoplasty, percutaneous aortic valve replacement, or other procedures described herein.

A delivery system and method for percutaneous aortic valve (PAV) replacement and apparatus used therein. A temporary aortic valve comprised of a reversibly expandable occluding means, such as balloons, surrounds a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The temporary valve with occluding means substitutes for the function of the native aortic valve during its replacement. The native aortic valve is next dilated, and then ablated through deployment of low profile, elongated, sequentially delivered stents. The ablation stent(s) displace the native valve tissues and remain within the aortic annulus to receive and provide a structure for retaining the PAV. The PAV is delivered, positioned and deployed within the ablation stent(s) at the aortic annulus with precision and relative ease. Ablation of the native aortic valve removes the structural obstacles to precise PAV placement. The temporary aortic valve mediates the hemodynamic forces upon the devices as encountered by the surgeon following native valve ablation. The temporary valve also promotes patient stability through continuous coronary perfusion and a moderated transvalvular pressure gradient and regurgitation. Sequential delivery of low profile PAV components minimize the risk of trauma and injury to vascular tissues. Mathematical considerations for determining the optimum cross-sectional area for the temporary valve blood perfusion gaps are also described.

Inflatable medical devices and methods for making and using the same are disclosed. The inflatable medical devices can be medical balloons. The balloons can be configured to have a through-lumen or no through-lumen and a wide variety of geometries. The device can have a high-strength, non-compliant, fiber-reinforced, multi-layered wall. The inflatable medical device can be used for angioplasty, kyphoplasty, percutaneous aortic valve replacement, or other procedures described herein.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures.

Inflatable medical devices and methods for making and using the same are disclosed. The inflatable medical devices can be medical balloons. The balloons can be configured to have a through-lumen or no through-lumen and a wide variety of geometries. The device can have a high-strength, non-compliant, fiber-reinforced, multi-layered wall. The inflatable medical device can be used for angioplasty, kyphoplasty, percutaneous aortic valve replacement, or other procedures described herein.

A method for percutaneous aortic valve (PAV) replacement and a temporary aortic valve used to facilitate the same. The temporary valve is comprised of a reversibly expandable occluding means, such as balloons, surrounding a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The native aortic valve is next dilated, and then ablated through deployment of an ablation stent. The ablation stent displaces the native valve tissues and remains within the aortic annulus to receive and retain the PAV. The PAV can then be positioned and deployed within the ablation stent with precision and ease. Ablation of the native aortic valve removes the structural obstacles to precise PAV placement. The temporary aortic valve mediates the hemodynamic forces encountered by the surgeon following native valve ablation. The temporary valve also promotes patient stability through continuous coronary perfusion and a moderated transvavlular pressure gradient. Mathematical considerations for determining the optimum cross-sectional area for the temporary valve blood perfusion gaps are also described.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures. The preferred delivery device includes a catheter having a deployment mechanism attached to its distal end, and a handle mechanism attached to its proximal end. A plurality of tethers are provided to selectively restrain the valve during deployment. A number of mechanisms for active deployment of partially expanded prosthetic valves are also described.

A catheter adapted for placement in the ascending aorta comprises a central catheter mechanism and a balloon structure or other occluding structure at its distal end. The catheter may be placed over the aortic arch such that the balloon structure is placed in the ascending aorta just above the Sinus of Valsalva and coronary ostia. Once in place, the balloon structure is inflated to control blood flow through the aorta during aortic valve ablation and replacement protocols.

Inflatable medical devices and methods for making and using the same are disclosed. The inflatable medical devices can be medical balloons. The balloons can be configured to have a through-lumen or no through-lumen and a wide variety of geometries. The device can have a high-strength, non-compliant, fiber-reinforced, multi-layered wall. The inflatable medical device can be used for angioplasty, kyphoplasty, percutaneous aortic valve replacement, or other procedures described herein.

Embodiments of the present invention provide apparatus and methods for embolic filtering during percutaneous valve replacement and repair procedures. Under one aspect, an apparatus comprises a sheath and a filter. The sheath has proximal and distal ends and a lumen therebetween. The distal end may be introduced into the aortic arch via the peripheral arteries and ascending aorta, while the proximal end may be disposed outside of the body. The lumen permits percutaneous aortic valve replacement or repair therethrough. The filter has a frame with an inlet and an outlet and an emboli-filtering mesh attached to the frame. The inlet is substantially spans the aortic arch in a region between the aortic valve and the great arteries. The outlet is coupled to the distal end of the sheath without leaving any gaps through which emboli could pass and without obstructing the lumen at the distal end of the sheath.

The invention relates to a percutaneous aortic valve replacement surgery conveying device with valve positioning function, which is characterized by comprising a conveying rod (1), a sheath pipe (5), a circular ring (3), positioning rods (2) and circular ring control cables (4), wherein the circular ring (3) is sheathed on the lower end of the percutaneous aortic valve replacement surgery conveying rod (1) and located in the conveying sheath pipe (5); the quantity of the positioning rods (2) is at least two, and one end of each positioning rod (2) is hinged with the conveying rod (1); and the quantity of the circular ring control cables (4) is at least two, the lower end of each circular ring control cable (4) is provided with a structure for supporting the circular ring (3), and the upper end of each circular ring control cable (4) stretches out of the human body along the axial direction of the conveying rod (1). The conveying device can play good auxiliary function on positioning the transplanted valve, increase the success rate of percutaneous aortic valve replacement surgery and reduce surgery difficulty and postoperative complications; the conveying device can also reduce surgery pain and risk for patients and decreases medical expenses.

A conveying appliance with valve locating function for use during percutaneous aortic valve replacement operation includes a conveying rod (1), a sheath pipe (5), a round ring (3), at least two locating rods (2) and at least two round ring operating ropes (4). The round ring (3) is sleeved on the lower end of the conveying rod (1) and located in the conveying sheath pipe (5). An end of the locating rod (2) is hinged on the conveying rod (1) and the hinge point is located on the upper portion of the round ring (3). A lower end of the round ring operating rope (4) is provided with a structure for supporting the round ring (3) or is directly connected with the round ring (3). An upper end of the round ring operating rope (4) extends out of a human body along the axial direction of the conveying rod (1). The appliance can locate the implanted valve in a better manner so as to increase the success rate of percutaneous aortic valve replacement operation and reduce the operation difficulty and the postoperative complications. The appliance reduces the pain and the risk of the operation, and lowers the medical cost.

The invention discloses a PAVR (Percutaneous Aortic Valve Replacement) operation conveying device with a valve positioning function. The device comprises an active valve, a gripping device, a positioning rod, a regulating line, a hinge pin, an ultrasonic transducer, a microwave probe, a control device, a power supply device and a shell; the active valve is arranged at the tail end of the gripping device; the other end of the gripping device is connected with the positioning rod; the ultrasonic transducer is arranged at the right side of the shell; the tail end of the ultrasonic transducer is connected with the device shell by the hinge pin; the tail end of the ultrasonic transducer is connected with the regulating line; the control device is arranged at the outer end of the shell; the power supply device is connected with the control device. The PAVR operation conveying device with the valve positioning function has a simple structure and can take a good assisting effect on positioning on an implanted valve; intelligent control of the control device can improve a success rate of a PAVR operation, reduce operation difficulty, reduce postoperative complications, reduce operation pain and risks for patients, and reduce medical cost.

The invention provides a new percutaneous aortic valve replacing device which is characterized by the rational designation, convenient usage and low operational danger, which is to solve problems of inconvenient stitching of valve and cradle and high danger of using saccule to expand aortic valve in current aortic valve replacing device, the device is an automatic buckling cradle carrying biological valve, comprising cradle in nickel-tantalum alloy framework and trilobular one-way opening valve composed of pig heart bag. The nickel-tantalum alloy possesses functions of fixing and supporting, the trilobular valve is fixed tightly in the cradle. The product is characterized by the small injury, high safety, reduced complication caused by aortic valve replacement, and wide application prospect.

Prosthetic valves and their component parts are described, as are prosthetic valve delivery devices and methods for their use. The prosthetic valves are particularly adapted for use in percutaneous aortic valve replacement procedures. The delivery devices are particularly adapted for use in minimally invasive surgical procedures. The preferred delivery device includes a catheter having a deployment mechanism attached to its distal end, and a handle mechanism attached to its proximal end. A plurality of tethers are provided to selectively restrain the valve during deployment. A number of mechanisms for active deployment of partially expanded prosthetic valves are also described.

Embodiments of the present invention provide apparatus and methods for embolic filtering during percutaneous valve replacement and repair procedures. Under one aspect, an apparatus comprises a sheath and a filter. The sheath has proximal and distal ends and a lumen therebetween. The distal end may be introduced into the aortic arch via the peripheral arteries and ascending aorta, while the proximal end may be disposed outside of the body. The lumen permits percutaneous aortic valve replacement or repair therethrough. The filter has a frame with an inlet and an outlet and an emboli-filtering mesh attached to the frame. The inlet is substantially spans the aortic arch in a region between the aortic valve and the great arteries. The outlet couples to the distal end of the sheath without leaving any gaps through which emboli could pass and without obstructing the lumen at the distal end of the sheath.

A catheter adapted for placement in the ascending aorta comprises a central catheter mechanism and a balloon structure or other occluding structure at its distal end. The catheter may be placed over the aortic arch such that the occluding structure is placed in the ascending aorta just above the Sinus of Valsalva and coronary ostia. Once in place, the occluding structure is inflated to control blood flow through the aorta during aortic valve ablation and replacement protocols.

A delivery system and method for percutaneous aortic valve (PAV) replacement and apparatus used therein. A temporary aortic valve including a reversibly expandable occluding means surrounds a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The temporary valve substitutes for the function of the native aortic valve during its replacement. The native aortic valve is next dilated, and then ablated through deployment of low profile, elongated, sequentially delivered stents. The stent(s) displace the native tissues and remain within the aortic annulus to receive and provide a structure for retaining the PAV. The PAV is delivered, positioned and deployed within the stent(s) at the aortic annulus with precision and relative ease.

The invention discloses a coronary artery protection catheter for a percutaneous aortic valve replacement, and a use method for the coronary artery protection catheter. The coronary artery protectioncatheter comprises a head tube and a tail tube and is characterized in that the shape of the head tube is a three-dimensional annular vortex shape; the head tube is provided with a plurality of firstthrough small holes for through connection; the inner end of the head tube is an open end; the outer end of the head tube is provided with a first catheter body for fixed through connection; the firstcatheter body is provided with the tail tube for bent through connection; the tail tube is provided with second through small holes; and the tail end of the tail tube is provided with a leading-in hole for fixed connection. The device simplifies an operation process through the head tube, the first catheter body and the tail tube, wherein the head tube, the first catheter body and the tail tube are made of elastic medical materials. In addition, in a process, the coronary artery orifice can prevent from being injured. When the coronary artery orifice is blocked after an artificial valve is implanted, blood can reach the holes on the head tube via a central cavity through the holes on the tail tube so as to supply the blood to the coronary sinus and the coronary artery.